Jeffrey Augustine
Optometrist · Brecksville, OHNPI 1538343561
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Carl Zeiss Meditec, Inc. accounts for 78.8% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $7,324 and has fallen 82.2% since, to $1,306 in 2025. Among optometrist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $321.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$18K
- Carl Zeiss Meditec USA, Inc.$4K
- Eyevance Pharmaceuticals LLC$283
- Ocular Therapeutix, Inc.$146
- Staar Surgical Company$105
- AbbVie$103
- plus $447 from 10 others
What the payments were for
- Consulting fees$6,50028%
- Speaking & faculty fees$10,80047%
- Travel & lodging$3,05813%
- Food & beverage$2,44911%
- Education$420%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 28 | $18,000 |
| Carl Zeiss Meditec USA, Inc. | 10 | $3,764 |
| Eyevance Pharmaceuticals LLC | 3 | $283 |
| Ocular Therapeutix, Inc. | 1 | $146 |
| Staar Surgical Company | 3 | $105 |
| AbbVie(2 entities) | 5 | $103 |
| Shire North American Group Inc | 5 | $100 |
| Dompe US, Inc. | 3 | $79 |
| Bausch & Lomb Americas Inc. | 3 | $61 |
| Novartis | 3 | $52 |
| Tarsus Pharmaceuticals, Inc. | 2 | $39 |
| Sight Sciences, Inc. | 1 | $30 |
| NEW World Medical,inc. | 1 | $28 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $22 |
| Alcon | 1 | $20 |
| Kala Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,849 in reported general payments places this provider in the 95th percentile of 1,995 optometrist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 23 | $488 |
| Ofloxacin | 25 | $185 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Brecksville
- Mile BrujicBowling Green$1.3M
- Gregory DenaeyerColumbus$846K
- Cory LappinMontgomery$367K
- Chris SmileyColumbus$305K
- Thomas ChesterCleveland$300K
- Carly RoseCincinnati$203K
- Wendy HallierReynoldsburg$200K
- John LahrCincinnati$145K
- Erin RueffColumbus$131K
- Mary YackeyCincinnati$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.